About
Contact
Subscribe
e-Edition

Make Home Page

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook
Twitter

- Site search

Home
News
Sports
- Local Sports
- National Sports
Business
Opinion
A & E
Life
Features & Magazines
Classifieds
Weather
Obituaries
Parcel Pickup

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

48.61 +0.32 (+0.66%)

Official Closing Price Updated: 7:00 PM EST, Dec 19, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GSK plc American Depositary Shares (Each representing two Ordinary Shares)

< Previous 1 2

...

30 31 32 33 34 35 36 37 38

...

42 43 Next >

A Look Into GlaxoSmithKline's Price Over Earnings ↗

February 07, 2022

Via Benzinga

Key Events This Week: All Eyes On The CPI ↗

February 07, 2022

After what DB's Jim Reid describes as

Via Talk Markets

A News Blizzard ↗

February 04, 2022

Markets are still down despite very encouraging news in January when 467,00 new hires got jobs.

Via Talk Markets

Sanofi Records Q4 Topline, Bottomline Growth As Blockbuster Eczema Drug Soars ↗

February 04, 2022

Sanofi SA's (NASDAQ: SNY)

Via Benzinga

GSK To Get $1.25B As Settlement For HIV Treatment Drug Patent Row With Gilead ↗

February 02, 2022

GlaxoSmithKline plc (NYSE: GSK) has settled a patent dispute between ViiV Healthcare and Gilead Sciences Inc (NASDAQ: GILD).

Via Benzinga

Watch for Continued Gains in Shares of GlaxoSmithKline PLC (GSK)

January 14, 2022

Via Investor Brand Network

World Markets News for Tuesday ↗

February 01, 2022

Exxon is splitting into 3 with its new restructuring move: upstream; chemicals; and low-carbon.

Via Talk Markets

FDA Approves First Injectable For HIV Pre-Exposure Prevention - GSK, Pfizer Backed Treatment ↗

February 01, 2022

The FDA has approved ViiV Healthcare's Apretude (cabotegravir extended-release injectable suspension

Via Benzinga

Panic reversal ↗

January 26, 2022

Crude oil inventories turned out to be fuller than expected, helping reduce the oil price rise.

Via Talk Markets

10 Stocks to Buy That Could Make You a Millionaire in 2022 ↗

January 26, 2022

After this past year, it's going to be hard to find stocks to buy to make you a millionaire in 2022. Here are 10 that might do the trick.

Via InvestorPlace

Markets Fears ↗

January 24, 2022

Today markets dropped precipitously over fear of a Ukrainian invasion and higher interest rates and inflation.

Via Talk Markets

FDA Clears Lyell Immunopharma' LYL132 Trial For Solid Tumors ↗

January 24, 2022

The FDA has cleared Lyell Immunopharma Inc's (NASDAQ: LYEL) Investigational New Drug (IND) application to initiate a Phase 1 trial for LYL132 in solid tumors....

Via Benzinga

Activist Investor Nelson Peltz's Fund Buys Stake In Unilever: FT ↗

January 23, 2022

Trian Fund Management LP, the activist hedge fund run by Nelson Peltz, has built a stake in Unilever PLC (NYSE: UL), the Financial Times reports, citing people with direct...

Via Benzinga

Routine Vaccination Rates in Teens and Adults Continue to Lag Behind Pre-Pandemic Levels, Follow-up Analysis Shows

January 21, 2022

From GSK

Via Business Wire

Why Jim Cramer Like NextEra Energy And Lincoln Electric? ↗

January 21, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said NextEra Energy, Inc. (NYSE:

Via Benzinga

World Markets News ↗

January 20, 2022

Today oil and gas inventories were seen as higher than expected while potential prices fell, both bullish.

Via Talk Markets

Wednesday File ↗

January 19, 2022

It sound odd but the real threat to markets is slowing Chinese growth which fell to 4% in Q4 from double that earlier last year.

Via Talk Markets

Chopped Stocks ↗

January 18, 2022

The day's theme is sell tech and buy banks.

Via Talk Markets

23andMe Pivoting To Clinical Research: Could That Lead To A Turnaround For The Stock? ↗

January 18, 2022

Genetic testing company 23andMe Holding Co. (NASDAQ: ME) took the unconventional route of a SPAC deal to go public, and the stock hasn't gained much traction since it began...

Via Benzinga

GSK Spurns $68.4B Bid From Unilever For Its Consumer Healthcare Business, Opts to Spin-off The Unit ↗

January 15, 2022

GlaxoSmithKline rejects three purchase offers from Unilever for its Consumer Healthcare business. The U.K. pharma giant says the business is well-positioned to...

Via Benzinga

More Serious Matters ↗

January 14, 2022

Wall Street fell on new worries about inflation and a drop in retail sales levels.

Via Talk Markets

Watch for Continued Gains in Shares of GlaxoSmithKline PLC (GSK) ↗

January 14, 2022

This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Shares of GlaxoSmithKline PLC (NYSE: GSK...

Via Benzinga

WHO Recommends Glaxo, Eli Lilly Drugs For COVID-19 Treatment Amid Omicron Surge ↗

January 14, 2022

An expert panel at the World Health Organization (WHO) recommended the use of treatments developed by Eli Lilly And Co (NYSE: LLY) and GlaxoSmithKline Plc...

Via Benzinga

Two Curses Of The Current Year ↗

January 13, 2022

The good news on inflation after this week's shocker is that December wholesale prices only rose 0.2%.

Via Talk Markets

GSK, Vir Biotech File For Emergency Use Nod For Intramuscular Sotrovimab For COVID-19 ↗

January 13, 2022

GlaxoSmithKline plc (NYSE: GSK) and Vir Biotechnology Inc (NASDAQ: VIR) have applied to the FDA to include intramuscular (IM) administration to sotrovimab...

Via Benzinga

Adagio's COVID-19 Antibody Has Neutralizing Activity Comparable To Other Antibodies ↗

January 13, 2022

Adagio Therapeutics Inc (NASDAQ: ADGI) shares gain during the premarket session after recent findings showing that ADG20 has neutralization activity against the omicron...

Via Benzinga

US To Purchase 600K Additional Doses of GSK-Vir's COVID-19 Antibody Therapy ↗

January 11, 2022

The U.S. has agreed to buy 600,000 more doses of GlaxoSmithKline plc (NYSE: GSK) and Vir Biotechnology Inc's (NASDAQ: VIR) COVID-19 antibody...

Via Benzinga

CureVac Outlines Upcoming Catalysts For Vaccine Programs ↗

January 10, 2022

Ahead of J.P. Morgan Healthcare Conference, CureVac BV (NASDAQ: CVAC) outlined the timeline for its vaccine programs. CureVac's preclinical second-...

Via Benzinga

Market Briefing For Wednesday, Jan. 5 ↗

January 05, 2022

Rising interest rates have yet to spark overt action by the Fed nor yet to cool-off the hot real estate market. However, the Nasdaq was hit hard, presumably as the 10-year rallied.

Via Talk Markets

Market Trend: Erratic And Unreliable ↗

December 29, 2021

Given the risks of covid variants and hefty price rises, the stock market should not be as buoyant as it is.

Via Talk Markets

< Previous 1 2

...

30 31 32 33 34 35 36 37 38

...

42 43 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Opinion
Photo Galleries
Videos
Local Events
Classifieds
Obituaries

Services

About
Contact
Personnel
Advertise
Subscription Services
Promote Your Event
Dealer Locations
Email Alerts
Submission Forms

Contact Information

chroniclejournal.com
75 S. Cumberland Street
Thunder Bay, ON P7B 1A3
Phone: 807 343 6200
Email: circulation@chroniclejournal.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

All News about GSK plc American Depositary Shares (Each representing two Ordinary Shares)

Sections

Services

Contact Information

Follow Us